These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1018 related items for PubMed ID: 16286049

  • 1. Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.
    Mohey R, Jørgensen LB, Møller BK, Black FT, Kjems J, Obel N.
    J Clin Virol; 2005 Dec; 34(4):257-67. PubMed ID: 16286049
    [Abstract] [Full Text] [Related]

  • 2. Dynamics of proviral HIV-1 184M/V in circulating CD4+ T-cells: a 90 days follow-up study after initiation/switch of HAART.
    Mohey R, Katzenstein TL, Black FT, Kjems J, Obel N.
    Scand J Infect Dis; 2006 Dec; 38(2):119-23. PubMed ID: 16449003
    [Abstract] [Full Text] [Related]

  • 3. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
    Pariente N, Pernas M, de la Rosa R, Gómez-Mariano G, Fernández G, Rubio A, López M, Benito JM, López-Galíndez C, Leal M, Domingo E, Martinez MA, Mas A.
    J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
    [Abstract] [Full Text] [Related]

  • 4. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.
    Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [Abstract] [Full Text] [Related]

  • 5. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
    Rodes B, García F, Gutierrez C, Martinez-Picado J, Aguilera A, Saumoy M, Vallejo A, Domingo P, Dalmau D, Ribas MA, Blanco JL, Pedreira J, Perez-Elias MJ, Leal M, de Mendoza C, Soriano V, Red de Investigación en SIDA.
    J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
    [Abstract] [Full Text] [Related]

  • 6. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
    Gibellini D, Vitone F, Schiavone P, Ponti C, La Placa M, Re MC.
    J Clin Virol; 2004 Apr; 29(4):282-9. PubMed ID: 15018857
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HIV-1 DNA and RNA kinetics in primary HIV infection.
    Lillo F, Grasso M, Lodini S, Capiluppi B, Lazzarin A, Tambussi G.
    J Biol Regul Homeost Agents; 2002 Apr; 16(1):49-52. PubMed ID: 12003174
    [Abstract] [Full Text] [Related]

  • 9. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.
    Re MC, Vitone F, Biagetti C, Schiavone P, Alessandrini F, Bon I, de Crignis E, Gibellini D.
    Clin Microbiol Infect; 2010 Jun; 16(6):640-6. PubMed ID: 19732081
    [Abstract] [Full Text] [Related]

  • 10. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
    Steel A, Cox AE, Shamji MH, John L, Nelson M, Henderson DC, Gotch FM, Gazzard BG, Kelleher P.
    Antivir Ther; 2007 Jun; 12(6):971-5. PubMed ID: 17926652
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.
    Carr JM, Cheney KM, Coolen C, Davis A, Shaw D, Ferguson W, Chang G, Higgins G, Burrell C, Li P.
    J Clin Microbiol; 2007 Apr; 45(4):1288-97. PubMed ID: 17314225
    [Abstract] [Full Text] [Related]

  • 14. Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy.
    Sarmati L, Nicastri E, Montano M, Dori L, Buonomini AR, d'Ettorre G, Gatti F, Parisi SG, Vullo V, Andreoni M.
    J Med Virol; 2004 Apr; 72(4):511-6. PubMed ID: 14981751
    [Abstract] [Full Text] [Related]

  • 15. Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy.
    Sarmati L, Parisi SG, Nicastri E, d'Ettorre G, Palmisano L, Andreotti M, Andreoni C, Giuliano M, Gatti F, Boldrin C, Palù G, Vullo V, Vella S, Andreoni M.
    J Clin Microbiol; 2005 Dec; 43(12):6183-5. PubMed ID: 16333125
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
    Delaugerre C, Gourlain K, Tubiana R, Carcelain G, Marcelin AG, Chouquet C, Mouroux M, Duvivier C, Autran B, Costagliola D, Katlama C, Calvez V.
    Antivir Ther; 2003 Jun; 8(3):233-7. PubMed ID: 12924540
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S, Garrido C, Youngpairoj AS, McNulty A, Zahonero N, Corral A, Heneine W, de Mendoza C, García-Lerma JG.
    AIDS; 2007 Nov 30; 21(18):2503-11. PubMed ID: 18025887
    [Abstract] [Full Text] [Related]

  • 20. Control of HIV-1 RNA load after HAART interruption: relationship with CCR5 co-receptor density and proviral DNA load in HIV-infected patients.
    Soriano-Sarabia N, Vallejo A, Fernández G, Genebat M, Gutiérrez S, Muñoz-Fernández MA, Leal M.
    J Clin Virol; 2007 Sep 30; 40(1):64-7. PubMed ID: 17662650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.